Blue Honeysuckle Extract Ameliorates Hyperuricemia by Modulating Gut Microbiota and Improving Liver–Kidney–Gut Axis Function
Antioxidants · 14.08.2026 · 15 (8) · 1015
DOI: 10.3390/antiox15081015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 14.08.2026. Verfasst von Xinyu Heng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, Xishan Hospital Affiliated to Jiangnan University (Preparatory), Jiangnan University, Wuxi 214105, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project of the Ministry of Science and Technology of China, Scientific Research Program of Wuxi Health Commission.
Abstract (Originalsprache)
Hyperuricemia (HUA) is a chronic metabolic disorder resulting from abnormal uric acid (UA) metabolism. Common clinical drugs for HUA have serious and inevitable adverse effects. Blue honeysuckle (Lonicera caerulea L.), a traditional edible berry with antioxidant and anti-inflammatory properties, shows great potential for alleviating HUA. This study prepared blue honeysuckle extract (BHE) and identified its main components as chlorogenic acid, quercetin, kaempferol, anthocyanin, etc., using LC-MS analysis. After in vitro digestion, BHE at concentrations ≥ 10 mg/mL retained over 70% of active components and biological activities. In HUA mice, BHE reduced serum UA levels, alleviated oxidative stress and inflammation, decreased UA production by inhibiting xanthine oxidase activity, and promoted renal and intestinal UA excretion through dual regulation of urate transporters. Additionally, BHE repaired the intestinal barrier, remodeled the gut microbiota structure, and improved UA metabolism disorders. This study supports BHE as a potential functional food ingredient for alleviating HUA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Central Laboratory, Xishan Hospital Affiliated to Jiangnan University (Preparatory), Jiangnan University, Wuxi 214105, China.
- MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
- Department of Clinical Laboratory, Xishan Hospital Affiliated to Jiangnan University (Preparatory), Jiangnan University, Wuxi 214105, China.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project of the Ministry of Science and Technology of China
- Scientific Research Program of Wuxi Health Commission
- Scientific Research Fund of Xishan People's Hospital of Wuxi City
- Scientific Research Fund of Xishan People’s Hospital of Wuxi City
Zitieren
APA
Heng, X., Huang, S., Luo, Q., Zhang, K., Liu, P., Zhu, Y., Deng, R., Sun, N., Qian, C., Ye, C., & Yang, H. (2026). Blue Honeysuckle Extract Ameliorates Hyperuricemia by Modulating Gut Microbiota and Improving Liver–Kidney–Gut Axis Function. Antioxidants, 15(8), 1015. https://doi.org/10.3390/antiox15081015
Vancouver
Heng X, Huang S, Luo Q, Zhang K, Liu P, Zhu Y, et al. Blue Honeysuckle Extract Ameliorates Hyperuricemia by Modulating Gut Microbiota and Improving Liver–Kidney–Gut Axis Function. Antioxidants. 2026;15(8):1015. doi:10.3390/antiox15081015
BibTeX
@article{Heng2026,
author = {Heng, Xinyu and Huang, Shaohong and Luo, Qingyao and Zhang, Ke and Liu, Pei and Zhu, Yanan and Deng, Ruoxuan and Sun, Ning and Qian, Chen and Ye, Chao and Yang, Hai},
title = {Blue Honeysuckle Extract Ameliorates Hyperuricemia by Modulating Gut Microbiota and Improving Liver–Kidney–Gut Axis Function},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {8},
pages = {1015},
doi = {10.3390/antiox15081015}
}
EUVIMED